Table of Content

1 Report Overview
1.1 Anti-Malarial Drug Definition
1.2 Market by Type
1.2.1 Global Anti-Malarial Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Vivax
1.2.4 Plasmodium Malariae
1.2.5 Plasmodium Ovale
1.3 Market Segment by Application
1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Anti-Malarial Drug Sales
2.1 Global Anti-Malarial Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Anti-Malarial Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Anti-Malarial Drug Revenue by Region
2.3.1 Global Anti-Malarial Drug Revenue by Region (2018-2023)
2.3.2 Global Anti-Malarial Drug Revenue by Region (2024-2034)
2.4 Global Anti-Malarial Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Anti-Malarial Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Anti-Malarial Drug Sales Quantity by Region
2.6.1 Global Anti-Malarial Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Anti-Malarial Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Anti-Malarial Drug Sales Quantity by Manufacturers
3.1.1 Global Anti-Malarial Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Anti-Malarial Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Sales in 2024
3.2 Global Anti-Malarial Drug Revenue by Manufacturers
3.2.1 Global Anti-Malarial Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Anti-Malarial Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Revenue in 2024
3.3 Global Anti-Malarial Drug Sales Price by Manufacturers
3.4 Global Key Players of Anti-Malarial Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-Malarial Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-Malarial Drug, Product Offered and Application
3.8 Global Key Manufacturers of Anti-Malarial Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Anti-Malarial Drug Sales Quantity by Type
4.1.1 Global Anti-Malarial Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Anti-Malarial Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Anti-Malarial Drug Revenue by Type
4.2.1 Global Anti-Malarial Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Anti-Malarial Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
4.3 Global Anti-Malarial Drug Price by Type
4.3.1 Global Anti-Malarial Drug Price by Type (2018-2023)
4.3.2 Global Anti-Malarial Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Anti-Malarial Drug Sales Quantity by Application
5.1.1 Global Anti-Malarial Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Anti-Malarial Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Anti-Malarial Drug Revenue by Application
5.2.1 Global Anti-Malarial Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Anti-Malarial Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
5.3 Global Anti-Malarial Drug Price by Application
5.3.1 Global Anti-Malarial Drug Price by Application (2018-2023)
5.3.2 Global Anti-Malarial Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Anti-Malarial Drug Sales by Company
6.1.1 North America Anti-Malarial Drug Revenue by Company (2018-2023)
6.1.2 North America Anti-Malarial Drug Sales Quantity by Company (2018-2023)
6.2 North America Anti-Malarial Drug Market Size by Type
6.2.1 North America Anti-Malarial Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Anti-Malarial Drug Revenue by Type (2018-2034)
6.3 North America Anti-Malarial Drug Market Size by Application
6.3.1 North America Anti-Malarial Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Anti-Malarial Drug Revenue by Application (2018-2034)
6.4 North America Anti-Malarial Drug Market Size by Country
6.4.1 North America Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Anti-Malarial Drug Revenue by Country (2018-2034)
6.4.3 North America Anti-Malarial Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Anti-Malarial Drug Sales by Company
7.1.1 Europe Anti-Malarial Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Anti-Malarial Drug Revenue by Company (2018-2023)
7.2 Europe Anti-Malarial Drug Market Size by Type
7.2.1 Europe Anti-Malarial Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Anti-Malarial Drug Revenue by Type (2018-2034)
7.3 Europe Anti-Malarial Drug Market Size by Application
7.3.1 Europe Anti-Malarial Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Anti-Malarial Drug Revenue by Application (2018-2034)
7.4 Europe Anti-Malarial Drug Market Size by Country
7.4.1 Europe Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Anti-Malarial Drug Revenue by Country (2018-2034)
7.4.3 Europe Anti-Malarial Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Anti-Malarial Drug Sales by Company
8.1.1 China Anti-Malarial Drug Sales Quantity by Company (2018-2023)
8.1.2 China Anti-Malarial Drug Revenue by Company (2018-2023)
8.2 China Anti-Malarial Drug Market Size by Type
8.2.1 China Anti-Malarial Drug Sales Quantity by Type (2018-2034)
8.2.2 China Anti-Malarial Drug Revenue by Type (2018-2034)
8.3 China Anti-Malarial Drug Market Size by Application
8.3.1 China Anti-Malarial Drug Sales Quantity by Application (2018-2034)
8.3.2 China Anti-Malarial Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Anti-Malarial Drug Sales by Company
9.1.1 APAC Anti-Malarial Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Anti-Malarial Drug Revenue by Company (2018-2023)
9.2 APAC Anti-Malarial Drug Market Size by Type
9.2.1 APAC Anti-Malarial Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Anti-Malarial Drug Revenue by Type (2018-2034)
9.3 APAC Anti-Malarial Drug Market Size by Application
9.3.1 APAC Anti-Malarial Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Anti-Malarial Drug Revenue by Application (2018-2034)
9.4 APAC Anti-Malarial Drug Market Size by Region
9.4.1 APAC Anti-Malarial Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Anti-Malarial Drug Revenue by Region (2018-2034)
9.4.3 APAC Anti-Malarial Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-Malarial Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Anti-Malarial Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Anti-Malarial Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Anti-Malarial Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 GlaxoSmithKline Anti-Malarial Drug Products and Services
11.1.5 GlaxoSmithKline Anti-Malarial Drug SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Ranbaxy
11.2.1 Ranbaxy Company Information
11.2.2 Ranbaxy Overview
11.2.3 Ranbaxy Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Ranbaxy Anti-Malarial Drug Products and Services
11.2.5 Ranbaxy Anti-Malarial Drug SWOT Analysis
11.2.6 Ranbaxy Recent Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Information
11.3.2 Zydus Cadila Overview
11.3.3 Zydus Cadila Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Zydus Cadila Anti-Malarial Drug Products and Services
11.3.5 Zydus Cadila Anti-Malarial Drug SWOT Analysis
11.3.6 Zydus Cadila Recent Developments
11.4 Alvizia
11.4.1 Alvizia Company Information
11.4.2 Alvizia Overview
11.4.3 Alvizia Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Alvizia Anti-Malarial Drug Products and Services
11.4.5 Alvizia Anti-Malarial Drug SWOT Analysis
11.4.6 Alvizia Recent Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Overview
11.5.3 Bayer Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Bayer Anti-Malarial Drug Products and Services
11.5.5 Bayer Anti-Malarial Drug SWOT Analysis
11.5.6 Bayer Recent Developments
11.6 Ipca
11.6.1 Ipca Company Information
11.6.2 Ipca Overview
11.6.3 Ipca Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Ipca Anti-Malarial Drug Products and Services
11.6.5 Ipca Anti-Malarial Drug SWOT Analysis
11.6.6 Ipca Recent Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Overview
11.7.3 Merck Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Merck Anti-Malarial Drug Products and Services
11.7.5 Merck Anti-Malarial Drug SWOT Analysis
11.7.6 Merck Recent Developments
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Company Information
11.8.2 F. Hoffmann-La Roche Overview
11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Products and Services
11.8.5 F. Hoffmann-La Roche Anti-Malarial Drug SWOT Analysis
11.8.6 F. Hoffmann-La Roche Recent Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Overview
11.9.3 Novartis Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Novartis Anti-Malarial Drug Products and Services
11.9.5 Novartis Anti-Malarial Drug SWOT Analysis
11.9.6 Novartis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Anti-Malarial Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Pfizer Anti-Malarial Drug Products and Services
11.10.5 Pfizer Anti-Malarial Drug SWOT Analysis
11.10.6 Pfizer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-Malarial Drug Value Chain Analysis
12.2 Anti-Malarial Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Malarial Drug Production Mode & Process
12.4 Anti-Malarial Drug Sales and Marketing
12.4.1 Anti-Malarial Drug Sales Channels
12.4.2 Anti-Malarial Drug Distributors
12.5 Anti-Malarial Drug Customers
13 Market Dynamics
13.1 Anti-Malarial Drug Industry Trends
13.2 Anti-Malarial Drug Market Drivers
13.3 Anti-Malarial Drug Market Challenges
13.4 Anti-Malarial Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Malarial Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Plasmodium Falciparum
Table 3. Major Manufacturers of Plasmodium Vivax
Table 4. Major Manufacturers of Plasmodium Malariae
Table 5. Major Manufacturers of Plasmodium Ovale
Table 6. Global Anti-Malarial Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Anti-Malarial Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Anti-Malarial Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Anti-Malarial Drug Revenue Market Share by Region (2018-2023)
Table 10. Global Anti-Malarial Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Anti-Malarial Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Anti-Malarial Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (Units)
Table 13. Global Anti-Malarial Drug Sales by Region (2018-2023) & (Units)
Table 14. Global Anti-Malarial Drug Sales Market Share by Region (2018-2023)
Table 15. Global Anti-Malarial Drug Sales by Region (2024-2034) & (Units)
Table 16. Global Anti-Malarial Drug Sales Market Share by Region (2024-2034)
Table 17. Global Anti-Malarial Drug Sales Quantity by Manufacturers (2018-2023) & (Units)
Table 18. Global Anti-Malarial Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Anti-Malarial Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Anti-Malarial Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Anti-Malarial Drug Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Anti-Malarial Drug, Industry Ranking, 2021 VS 2024
Table 23. Global Anti-Malarial Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Malarial Drug as of 2024)
Table 25. Global Key Manufacturers of Anti-Malarial Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Anti-Malarial Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Anti-Malarial Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 30. Global Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 31. Global Anti-Malarial Drug Sales Quantity Share by Type (2018-2023)
Table 32. Global Anti-Malarial Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Anti-Malarial Drug Revenue Share by Type (2018-2023)
Table 36. Global Anti-Malarial Drug Revenue Share by Type (2024-2034)
Table 37. Anti-Malarial Drug Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Anti-Malarial Drug Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 40. Global Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 41. Global Anti-Malarial Drug Sales Quantity Share by Application (2018-2023)
Table 42. Global Anti-Malarial Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Anti-Malarial Drug Revenue Share by Application (2018-2023)
Table 46. Global Anti-Malarial Drug Revenue Share by Application (2024-2034)
Table 47. Anti-Malarial Drug Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Anti-Malarial Drug Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Anti-Malarial Drug Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Anti-Malarial Drug Sales Quantity by Company (2018-2023) & (Units)
Table 51. North America Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 52. North America Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 53. North America Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 56. North America Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 57. North America Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Anti-Malarial Drug Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Anti-Malarial Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Anti-Malarial Drug Sales Quantity by Country (2018-2023) & (Units)
Table 63. North America Anti-Malarial Drug Sales Quantity by Country (2024-2034) & (Units)
Table 64. Europe Anti-Malarial Drug Sales Quantity by Company (2018-2023) & (Units)
Table 65. Europe Anti-Malarial Drug Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 67. Europe Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 68. Europe Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 71. Europe Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 72. Europe Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Anti-Malarial Drug Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Anti-Malarial Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Anti-Malarial Drug Sales Quantity by Country (2018-2023) & (Units)
Table 78. Europe Anti-Malarial Drug Sales Quantity by Country (2024-2034) & (Units)
Table 79. China Anti-Malarial Drug Sales Quantity by Company (2018-2023) & (Units)
Table 80. China Anti-Malarial Drug Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 82. China Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 83. China Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 86. China Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 87. China Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Anti-Malarial Drug Sales Quantity by Company (2018-2023) & (Units)
Table 90. APAC Anti-Malarial Drug Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 92. APAC Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 93. APAC Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 96. APAC Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 97. APAC Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Anti-Malarial Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Anti-Malarial Drug Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Anti-Malarial Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Anti-Malarial Drug Sales Quantity by Region (2018-2023) & (Units)
Table 103. APAC Anti-Malarial Drug Sales Quantity by Region (2024-2034) & (Units)
Table 104. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Company (2018-2023) & (Units)
Table 105. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Type (2018-2023) & (Units)
Table 107. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Type (2024-2034) & (Units)
Table 108. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Application (2018-2023) & (Units)
Table 111. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Application (2024-2034) & (Units)
Table 112. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Anti-Malarial Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Country (2018-2023) & (Units)
Table 118. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity by Country (2024-2034) & (Units)
Table 119. GlaxoSmithKline Company Information
Table 120. GlaxoSmithKline Description and Overview
Table 121. GlaxoSmithKline Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. GlaxoSmithKline Anti-Malarial Drug Product and Services
Table 123. GlaxoSmithKline Anti-Malarial Drug SWOT Analysis
Table 124. GlaxoSmithKline Recent Developments
Table 125. Ranbaxy Company Information
Table 126. Ranbaxy Description and Overview
Table 127. Ranbaxy Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Ranbaxy Anti-Malarial Drug Product and Services
Table 129. Ranbaxy Anti-Malarial Drug SWOT Analysis
Table 130. Ranbaxy Recent Developments
Table 131. Zydus Cadila Company Information
Table 132. Zydus Cadila Description and Overview
Table 133. Zydus Cadila Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Zydus Cadila Anti-Malarial Drug Product and Services
Table 135. Zydus Cadila Anti-Malarial Drug SWOT Analysis
Table 136. Zydus Cadila Recent Developments
Table 137. Alvizia Company Information
Table 138. Alvizia Description and Overview
Table 139. Alvizia Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. Alvizia Anti-Malarial Drug Product and Services
Table 141. Alvizia Anti-Malarial Drug SWOT Analysis
Table 142. Alvizia Recent Developments
Table 143. Bayer Company Information
Table 144. Bayer Description and Overview
Table 145. Bayer Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. Bayer Anti-Malarial Drug Product and Services
Table 147. Bayer Anti-Malarial Drug SWOT Analysis
Table 148. Bayer Recent Developments
Table 149. Ipca Company Information
Table 150. Ipca Description and Overview
Table 151. Ipca Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Ipca Anti-Malarial Drug Product and Services
Table 153. Ipca Anti-Malarial Drug SWOT Analysis
Table 154. Ipca Recent Developments
Table 155. Merck Company Information
Table 156. Merck Description and Overview
Table 157. Merck Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 158. Merck Anti-Malarial Drug Product and Services
Table 159. Merck Anti-Malarial Drug SWOT Analysis
Table 160. Merck Recent Developments
Table 161. F. Hoffmann-La Roche Company Information
Table 162. F. Hoffmann-La Roche Description and Overview
Table 163. F. Hoffmann-La Roche Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 164. F. Hoffmann-La Roche Anti-Malarial Drug Product and Services
Table 165. F. Hoffmann-La Roche Anti-Malarial Drug SWOT Analysis
Table 166. F. Hoffmann-La Roche Recent Developments
Table 167. Novartis Company Information
Table 168. Novartis Description and Overview
Table 169. Novartis Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 170. Novartis Anti-Malarial Drug Product and Services
Table 171. Novartis Anti-Malarial Drug SWOT Analysis
Table 172. Novartis Recent Developments
Table 173. Pfizer Company Information
Table 174. Pfizer Description and Overview
Table 175. Pfizer Anti-Malarial Drug Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 176. Pfizer Anti-Malarial Drug Product and Services
Table 177. Pfizer Anti-Malarial Drug SWOT Analysis
Table 178. Pfizer Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Anti-Malarial Drug Distributors List
Table 182. Anti-Malarial Drug Customers List
Table 183. Anti-Malarial Drug Market Trends
Table 184. Anti-Malarial Drug Market Drivers
Table 185. Anti-Malarial Drug Market Challenges
Table 186. Anti-Malarial Drug Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Malarial Drug Product Picture
Figure 2. Global Anti-Malarial Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Anti-Malarial Drug Market Share by Type in 2024 & 2034
Figure 4. Plasmodium Falciparum Product Picture
Figure 5. Plasmodium Vivax Product Picture
Figure 6. Plasmodium Malariae Product Picture
Figure 7. Plasmodium Ovale Product Picture
Figure 8. Global Anti-Malarial Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Anti-Malarial Drug Market Share by Application in 2024 & 2034
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. E-Commerce
Figure 13. Others
Figure 14. Anti-Malarial Drug Report Years Considered
Figure 15. Global Anti-Malarial Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Anti-Malarial Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Anti-Malarial Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Anti-Malarial Drug Sales Quantity 2018-2034 (Units)
Figure 19. Global Anti-Malarial Drug Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Anti-Malarial Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Anti-Malarial Drug Sales Quantity YoY (2018-2034) & (Units)
Figure 22. North America Anti-Malarial Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Anti-Malarial Drug Sales Quantity YoY (2018-2034) & (Units)
Figure 24. Europe Anti-Malarial Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Anti-Malarial Drug Sales Quantity YoY (2018-2034) & (Units)
Figure 26. China Anti-Malarial Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Anti-Malarial Drug Sales Quantity YoY (2018-2034) & (Units)
Figure 28. APAC Anti-Malarial Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity YoY (2018-2034) & (Units)
Figure 30. Middle East, Africa and Latin America Anti-Malarial Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Anti-Malarial Drug Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Anti-Malarial Drug Revenue in 2024
Figure 33. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Anti-Malarial Drug Revenue Market Share by Company in 2024
Figure 39. North America Anti-Malarial Drug Sales Quantity Market Share by Company in 2024
Figure 40. North America Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Anti-Malarial Drug Revenue Share by Country (2018-2034)
Figure 45. North America Anti-Malarial Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Anti-Malarial Drug Sales Quantity Market Share by Company in 2024
Figure 49. Europe Anti-Malarial Drug Revenue Market Share by Company in 2024
Figure 50. Europe Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Anti-Malarial Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Anti-Malarial Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Anti-Malarial Drug Sales Quantity Market Share by Company in 2024
Figure 62. China Anti-Malarial Drug Revenue Market Share by Company in 2024
Figure 63. China Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Anti-Malarial Drug Sales Quantity Market Share by Company in 2024
Figure 68. APAC Anti-Malarial Drug Revenue Market Share by Company in 2024
Figure 69. APAC Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Anti-Malarial Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Anti-Malarial Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Anti-Malarial Drug Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Anti-Malarial Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Anti-Malarial Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Anti-Malarial Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Anti-Malarial Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Anti-Malarial Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Anti-Malarial Drug Value Chain
Figure 94. Anti-Malarial Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed